A simple “copy-and-paste” approach to introduce a rodent CDR into a human antibody scaffold will often diminish or destroy the binding specificity and affinity of the original rodent antibody. Humanization therefore will rely on discrete CDR residue substitutions to obtain an optimum balance of minimal immunogenicity toward the antibody, while maintaining the original binding and recognition characteristics.
In addition to our mouse monoclonal antibody platform and fully-human monoclonal antibody platform, ProMab can humanize your already established mouse monoclonal antibody or prepare one from scratch for your desired application.